KM4 also contains the androgen receptor (Ar), itself, suggesting that plumbagin may affect prostate cancer by directly down-regulating Ar, which is consistent with our previous observation that plumbagin causes reduction of Ar protein22. Here, AR is linked to prostate carcinoma.